ACR／AAHKS指南：服用抗风湿药物的风湿性疾病患者接受择期全髋或全膝关节置换术的围术期管理

SPECIAL ARTICLEAmerican College of Rheumatology/AmericanAssociation of Hip and Knee Surgeons Guideline for thePerioperative Management of Antirheumatic Medication inPatients With Rheumatic Diseases Undergoing ElectiveTotal Hip or Total Knee ArthroplastySusan M.Goodman,Bryan Springer,2 Gordon Guyatt,3 Matthew P.Abdel,4Vinod Dasa,3 Michael George,6 Ora Gewurz-Singer,?Jon T.Giles,Beverly Johnson,Steve Lee,Lisa A.Mandl,Michael A.Mont,Peter Sculco,Scott Sporer,12 Louis Stryker,13Marat Turgunbaev,4 Barry Brause,Antonia F.Chen,5 Jeremy Gililland,6 Mark Goodman,7Arlene Hurley-Rosenblatt,Kyriakos Kirou,Elena Losina,Ronald MacKenzie,Kaleb Michaud,20 Ted Mikuls,2 Linda Russell,Alexander Sah,22 Amy S.Miller,14Jasvinder A.Singh,23 and Adolph Yates!7Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR)areintended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient.The ACR considers adherence to the recommendations within this guideline to be voluntary,with the ultimate deter-mination regarding their application to be made by the physician in light of each patient's individual circumstances.Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guaranteeany specific outcome.Guidelines and recommendations developed and endorsed by the ACR are subject to periodicrevision as warranted by the evolution of medical knowledge,technology,and practice.ACR recommendations arenot intended to dictate payment or insurance decisions.These recommendations cannot adequately convey alluncertainties and nuances of patient care.The American College of Rheumatology is an independent,professional,medical and scientific society that does notguarantee,warrant,or endorse any commercial product or service.Objective.This collaboration between the Americanguideline for the perioperative management of antirheu-College of Rheumatology and the American Associationmatic drug therapy for adults with rheumatoid arthritisof Hip and Knee Surgeons developed an evidence-based(RA),spondyloarthritis (SpA)including ankylosingSVinod Dasa,MD:Louisiana State University,New Orleans;MichaelGeorge,MD:University of Pennsy lvania,Philadelphia;'Ora Gewurz-Singer,MD:University of Michigan,Ann Arbor;"Jon T.Giles,MD,MPH:Columbia University,New York,New York;"Beverly Johnson,MD:Albert Einstein College of Medicine,Bronx,New York;0SteveLee,DO:Kaiser Permanente,Fontana,California;Michael A.Mont,MD:Cleveland Clinic,Cleveland,Ohio:Scott Sporer,MD:Midwest Orthopaedics at Rush,Chicago,Illinois;Louis Stryker,OrthoCarolina Hip and Knee Center,Charlotte,North Carolina;Gordon Guyatt,MD:MeMaster University,Hamilton,Ontario,MD:University of Texas Medical Branch,Galveston;MaratTurgunbaev,MD,MPH,Amy S.Miller:American College of Rheu-Canada:"Matthew P.Abdel,MD:Mayo Clinic,Rochester,Minnesota:matology,Atlanta,Georgia;Antonia F.Chen,MD,MBA:Rothman